Can Viagra Protect Your Eyesight? The Surprising Link Between Sildenafil and Retinal Health
"New research explores how sildenafil citrate, commonly known as Viagra, could prevent cell damage in the retina and potentially protect against glaucoma."
Glaucoma, a group of eye diseases characterized by the gradual degeneration of the optic nerve, is a leading cause of irreversible blindness worldwide. This condition often results from the loss of retinal ganglion cells (RGCs), crucial neurons that transmit visual information from the eye to the brain. Elevated intraocular pressure (IOP) is a major risk factor for glaucoma, but vascular factors and reduced blood flow to the optic nerve also play a significant role.
Current treatments for glaucoma primarily focus on lowering IOP, but these methods have limitations and do not always prevent further vision loss. This has spurred researchers to explore new therapeutic approaches, including the potential use of sildenafil citrate (SC), a selective phosphodiesterase type 5 (PDE-5) inhibitor commonly known as Viagra. Sildenafil enhances vasodilation by increasing the smooth muscle-relaxant effects of nitric oxide, which could improve blood flow to the retina and protect RGCs.
A recent study published in the International Journal of Experimental Pathology has investigated the effects of sildenafil citrate on retinal cells in rats with induced ischemia-reperfusion (I/R) injury, a condition that mimics the vascular dysfunction seen in glaucoma. The study aimed to determine whether sildenafil could prevent retinal cell apoptosis (programmed cell death) and protect the RGC layer from damage. Here’s what they found.
How Does Sildenafil Protect Retinal Cells?

The study, conducted by researchers from Universidade Estadual Paulista and Koret School of Veterinary Medicine, involved inducing ischemia-reperfusion injury in the retinas of rats. Thirty-six rats were divided into a control group and two experimental groups that underwent I/R injury. The I/R groups were treated with either sildenafil citrate or a placebo for 7 or 21 days. The researchers then analyzed the retinas using various methods, including histology, morphometry, immunohistochemistry, and qRT-PCR to assess cell damage, protein expression, and gene expression levels.
- Reduced Inflammation: Sildenafil treatment reduced inflammatory responses in the retina, suggesting a protective effect against ischemia-induced damage.
- Preservation of RGCs: The RGC layer, which is critical for transmitting visual information, was better maintained in the sildenafil-treated groups.
- Modulation of Apoptosis: Sildenafil influenced the expression of genes involved in apoptosis, promoting cell survival by downregulating pro-apoptotic factors and upregulating anti-apoptotic factors.
A Promising New Avenue for Glaucoma Treatment?
These findings suggest that sildenafil citrate may have a protective effect on the retinal ganglion cell layer, preventing apoptosis and promoting cell survival. The researchers conclude that sildenafil treatment had a protective effect on the apoptosis pathways, with gene expression levels in the sildenafil groups similar to those of the control group. While further studies are needed to confirm these results in humans, this research opens up a promising new avenue for therapeutic intervention in glaucoma and other retinal conditions characterized by ischemia and neuronal cell death.